|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 7/08 | |
| C07K 14/00 | |||
| G01N 33/68 | |||
| A61K 39/395 | |||
| C07K 14/005 |
| (11) | Patento numeris | 2859011 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13727202.7 |
| Europos patento paraiškos padavimo data | 2013-06-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/061751 |
| Data | 2013-06-06 |
| (87) | Numeris | WO 2013/182661 |
| Data | 2013-12-12 |
| (30) | Numeris | Data | Šalis |
| 201261656256 P | 2012-06-06 | US |
| (72) |
S RENSEN, Birger, NO
ÖKVIST, Mats, NO
HOVDEN, Arnt Ove, NO
GR NVOLD, Maja Sommerfelt, NO
|
| (73) |
Bionor Immuno AS,
Klostergata 33 P.O. Box 2870, 3702 Skien,
NO
|
| (54) | PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS |
| PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS |